Phase II trial of a low dose nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unrecectable or recurrent advanced gastric cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 16 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 05 Nov 2014 New trial record